Published in Am J Gastroenterol on September 01, 1998
Is moderate red wine consumption safe in inactive inflammatory bowel disease? Digestion (2011) 1.49
Role of smoking in inflammatory bowel disease: implications for therapy. Postgrad Med J (2000) 1.20
Pattern of alcohol consumption and its effect on gastrointestinal symptoms in inflammatory bowel disease. Alcohol (2010) 1.01
Increased risk of both ulcerative colitis and Crohn's disease in a population suffering from COPD. Lung (2008) 0.98
Effects of current cigarette smoking on clinical course of Crohn's disease and ulcerative colitis. Dig Dis Sci (2001) 0.96
Nicotine treatment for ulcerative colitis. Br J Clin Pharmacol (1999) 0.87
Anti-TNF antibody treatment of Crohn's disease. Ann Rheum Dis (1999) 0.81
An oral formulation of nicotine for release and absorption in the colon: its development and pharmacokinetics. Br J Clin Pharmacol (1999) 0.79
Paracrine potential of fibroblasts exposed to cigarette smoke extract with vascular growth factor induction. Laryngoscope (2013) 0.77
Effect of general practitioners' advice against smoking. Br Med J (1979) 24.07
Comparison of tests used to distinguish smokers from nonsmokers. Am J Public Health (1987) 8.59
Antibodies to CD3/T-cell receptor complex induce death by apoptosis in immature T cells in thymic cultures. Nature (1989) 6.70
Absorption by non-smokers of carbon monoxide from room air polluted by tobacco smoke. Lancet (1973) 5.52
Changes in cigarette price and consumption by men in Britain, 1946-71: a preliminary analysis. Br J Prev Soc Med (1973) 5.35
Mechanism of antigen-driven selection in germinal centres. Nature (1990) 5.26
A rapid gas-liquid chromatographic method for the determination of cotinine and nicotine in biological fluids. J Pharm Pharmacol (1990) 4.84
Expired air carbon monoxide: a simple breath test of tobacco smoke intake. Br Med J (1980) 4.82
Relation of nicotine yield of cigarettes to blood nicotine concentrations in smokers. Br Med J (1980) 4.76
Transcription cell type specificity is conferred by an immunoglobulin VH gene promoter that includes a functional consensus sequence. Cell (1985) 4.38
Non-smoking: a feature of ulcerative colitis. Br Med J (Clin Res Ed) (1982) 4.08
Cigarette dependence: II. Doctor's role in management. Br Med J (1971) 3.99
Biochemical markers of smoke absorption and self reported exposure to passive smoking. J Epidemiol Community Health (1984) 3.95
Comparison of the effector functions of human immunoglobulins using a matched set of chimeric antibodies. J Exp Med (1987) 3.82
GAS5, a non-protein-coding RNA, controls apoptosis and is downregulated in breast cancer. Oncogene (2008) 3.79
Improved gas chromatographic method and micro-extraction technique for the measurement of nicotine in biological fluids. J Pharm Pharmacol (1979) 3.72
Realistic goals for smoking and health. A case for safer smoking. Lancet (1974) 3.68
Effect of nicotine chewing gum as an adjunct to general practitioner's advice against smoking. Br Med J (Clin Res Ed) (1983) 3.64
Activation of Epstein-Barr virus latent genes protects human B cells from death by apoptosis. Nature (1991) 3.61
Low-tar medium-nicotine cigarettes: a new approach to safer smoking. Br Med J (1976) 3.55
Death due to bioterrorism-related inhalational anthrax: report of 2 patients. JAMA (2001) 3.55
An oral preparation to release drugs in the human colon. Br J Clin Pharmacol (1982) 3.49
Incidence of Crohn's disease in Cardiff between 1934-1977. Gut (1979) 3.35
Smoking in Britain: strategy for future emancipation. Br J Addict Alcohol Other Drugs (1971) 3.06
Guidelines for the initial biopsy diagnosis of suspected chronic idiopathic inflammatory bowel disease. The British Society of Gastroenterology Initiative. J Clin Pathol (1997) 2.98
Randomised controlled trial of nicotine chewing-gum. Br Med J (Clin Res Ed) (1982) 2.92
Targeting heavy smokers in general practice: randomised controlled trial of transdermal nicotine patches. BMJ (1993) 2.91
Transdermal nicotine for active ulcerative colitis. N Engl J Med (1994) 2.90
Hyperresponsive B cells in CD22-deficient mice. Science (1996) 2.86
Increased reflux of bile into the stomach in patients with gastric ulcer. Gastroenterology (1969) 2.86
Passive smoking, salivary cotinine concentrations, and middle ear effusion in 7 year old children. BMJ (1989) 2.81
Plasma nicotine levels after smoking cigarettes with high, medium, and low nicotine yields. Br Med J (1975) 2.80
Clinical use of nicotine chewing-gum. Br Med J (1980) 2.79
Predictive factors for initial treatment response after circumferential radiofrequency ablation for Barrett's esophagus with early neoplasia: a prospective multicenter study. Endoscopy (2013) 2.76
Gastrointestinal manifestations of type 1 neurofibromatosis (von Recklinghausen's disease). Histopathology (1991) 2.75
Dose effects and predictors of outcome in a randomized trial of transdermal nicotine patches in general practice. Addiction (1995) 2.71
Cigarette smoking: natural history of a dependence disorder. Br J Med Psychol (1971) 2.71
Myelopoiesis in the zebrafish, Danio rerio. Blood (2001) 2.67
Natural history of patients with x-ray-negative dyspepsia in general practice. Br Med J (1972) 2.67
Comparison of effect on tobacco consumption and carbon monoxide absorption of changing to high and low nicotine cigarettes. Br Med J (1973) 2.65
A hapten-specific chimaeric IgE antibody with human physiological effector function. Nature (1985) 2.63
Elimination of cotinine from body fluids: implications for noninvasive measurement of tobacco smoke exposure. Am J Public Health (1988) 2.63
Magnifying endoscopy for diagnosing and delineating early gastric cancer. Endoscopy (2009) 2.62
Breakfast and dietary aspects of Crohn's disease. Br Med J (1978) 2.57
Passive exposure to tobacco smoke: saliva cotinine concentrations in a representative population sample of non-smoking schoolchildren. Br Med J (Clin Res Ed) (1985) 2.51
Fluorescence, reflectance, and light-scattering spectroscopy for evaluating dysplasia in patients with Barrett's esophagus. Gastroenterology (2001) 2.46
Higher dosage nicotine patches increase one-year smoking cessation rates: results from the European CEASE trial. Collaborative European Anti-Smoking Evaluation. European Respiratory Society. Eur Respir J (1999) 2.44
Microscopic activity in ulcerative colitis: what does it mean? Gut (1991) 2.43
Assay of nicotine in biological materials: sources of contamination and their elimination. J Pharm Pharmacol (1980) 2.43
Effect of nicotine chewing gum on smoking behaviour and as an aid to cigarette withdrawal. Br Med J (1976) 2.41
Colorectal cancer pathology reporting: a regional audit. J Clin Pathol (1997) 2.41
Preoperative assessment of prognostic factors in rectal cancer using high-resolution magnetic resonance imaging. Br J Surg (2003) 2.40
Cigarette smoking: a dependence on high-nicotine boli. Drug Metab Rev (1978) 2.36
Saliva cotinine as an indicator of cigarette smoking in adolescents. Br J Addict (1987) 2.33
Maintenance of remission in ulcerative colitis with oral preparation of 5-aminosalicylic acid. Br Med J (Clin Res Ed) (1982) 2.32
Blood carboxyhaemoglobin, plasma thiocyanate, and cigarette consumption: implications for epidemiological studies in smokers. Br Med J (Clin Res Ed) (1982) 2.32
Plasma nicotine levels after cigarette smoking and chewing nicotine gum. Br Med J (1976) 2.31
DNA replication licensing and human cell proliferation. J Cell Sci (2001) 2.30
Carboxyhaemoglobin and plasma thiocyanate: complementary indicators of smoking behaviour? Thorax (1982) 2.30
Rapid gas-liquid chromatographic determination of cotinine in biological fluids. Analyst (1980) 2.29
Apoptosis: molecular regulation of cell death. Eur J Biochem (1996) 2.29
Children's exposure to passive smoking in England since the 1980s: cotinine evidence from population surveys. BMJ (2000) 2.28
Thickness of adherent mucus gel on colonic mucosa in humans and its relevance to colitis. Gut (1994) 2.28
Demonstration of somatic mutation and colonic crypt clonality by X-linked enzyme histochemistry. Nature (1988) 2.28
Disodium cromoglycate in the treatment of chronic proctitis. Gut (1975) 2.21
What determines levels of passive smoking in children with asthma? Thorax (1997) 2.20
Determinants of passive smoking in children in Edinburgh, Scotland. Am J Public Health (1992) 2.17
Two transcriptional activators, CCAAT-box-binding transcription factor and heat shock transcription factor, interact with a human hsp70 gene promoter. Mol Cell Biol (1987) 2.17
Nicotine yield from machine-smoked cigarettes and nicotine intakes in smokers: evidence from a representative population survey. J Natl Cancer Inst (2001) 2.16
Prescription of transdermal nicotine patches for smoking cessation in general practice: evaluation of cost-effectiveness. Lancet (1999) 2.15
Granulomatous inflammation--a review. J Clin Pathol (1983) 2.15
Non-hepatic hyperammonaemia: an important, potentially reversible cause of encephalopathy. Postgrad Med J (2001) 2.14
Treatment of ulcerative colitis with oral disodium cromoglycate. A double-blind controlled trial. Lancet (1976) 2.13
Adjustment of smokers to dilution of tobacco smoke by ventilated cigarette holders. Clin Pharmacol Ther (1978) 2.09
Identification of 1,25-dihydroxyvitamin D3 receptors and activities in muscle. J Biol Chem (1985) 2.07
Macrophage heterogeneity in receptor activity: the activation of macrophage Fc receptor function in vivo and in vitro. J Immunol (1975) 2.07
Squamous carcinoma of the colorectum and its genesis. J Pathol (1979) 2.07
Colonic involvement in salmonellosis. Lancet (1976) 2.06